PROMETRIKA Announces The Availability Of Pharmacovigilance Services

Cambridge, MA /PRNewswire/ -- PROMETRIKA, LLC, a full-service clinical research organization (CRO) has expanded its offerings with the addition of pharmacovigilance services for clinical trials. PROMETRIKA has selected ARISg™, a world leader in safety data collection and reporting, as our service platform. Our drug safety and regulatory affairs professionals, and expert physicians, each with more than 23 years in the biopharmaceutical industry, provide clinical interpretation and monitoring of safety trends.

PROMETRIKA's CEO and President, Dr. Miganush Stepanians noted, "In response to our Sponsors' increasing needs for accurate and dependable safety monitoring and reporting, we now offer trial safety monitoring with the worldwide reporting capabilities crucial in today's drug development environment."

Pharmacovigilance services for all phases of clinical trials can be provided as a stand-alone service or in conjunction with clinical operations, monitoring, data management, biostatistics, and medical writing services offered by PROMETRIKA.

About PROMETRIKA

PROMETRIKA, LLC is a clinical research organization (CRO) supporting the biopharmaceutical and medical device industries since 2003. Based in Cambridge, Massachusetts, a biopharmaceutical hub, PROMETRIKA has provided more than 12 years of experienced, professional support to local, national, and international clients. For more information about the range of services offered by PROMETRIKA, please visit our website at http://www.prometrika.com.